The United Nations Conference on Trade and Development (UNCTAD) was established in 1964 to support economic development and promote fair participation in global trade, particularly for developing countries. Headquartered in Geneva, Switzerland, UNCTAD serves as a forum for countries to address challenges related to trade, investment, and development. UNCTAD’s primary role is to provide research, policy recommendations, and technical assistance to help countries integrate into the global economy. It focuses on issues such as trade policy, investment, finance, and sustainable development, with particular attention to least developed countries and vulnerable economies. The organization works at national, regional, and global levels to help countries diversify their economies, improve competitiveness, and manage challenges such as debt and market access. It also promotes international cooperation by connecting governments with funding, expertise, and development programs. Although UNCTAD does not directly implement large-scale infrastructure projects, it collaborates with international organizations to support long-term development efforts. Today, UNCTAD plays a key role in advancing inclusive economic growth, especially as developing countries face rising debt levels, unequal access to digital markets, and continued volatility in global trade and supply chains.

Patents grant inventors exclusive legal rights over their inventions. Patents are meant to reward companies for spending time and money to develop something new. Patent protection lasts about 20 years. However, companies can make small changes to the product and then apply for secondary patents to extend exclusive control. This delays cheaper generic medicines from becoming available. Thus, in healthcare, medicines are expensive. Companies can charge remarkably high prices because competitors cannot legally produce cheaper alternatives. As a result, some people cannot afford the critical medicines they need. For example, although tuberculosis has long been treatable, many people still die worldwide from the disease. Soaring prices, patent protections, and limited market access make essential medicines difficult to obtain. In developed countries, companies can maintain higher prices since some buyers can afford the cost. In less developed countries, the same prices can make medicines inaccessible. International agreements like the TRIPS Agreement were intended to give developing countries more flexibility. However, these new provisions can be complex to use, and TRIPS has not fully solved the challenge of making medicines affordable for everyone. With the health of billions on the line, there is tremendous urgency on a global scale to find a compromise on this pressing issue.

Foreign investment is often celebrated as an engine of development. It offers a way for less developed states to access capital, technology, and global markets they might not reach alone. But for many countries, the reality has proven more complicated. When foreign corporations dominate key industries, domestic competitors can struggle to survive. When international aid comes attached to conditions, governments can find their policy choices quietly constrained. UNCTAD was founded on the idea that the global economic system does not treat all countries equally and that developing countries deserve a forum to advocate for their own interests. In this committee, delegates will examine the tension at the heart of modern development: whether foreign investment accelerates economic development or locks it into relationships of dependency. Delegates will debate real policy questions: how to regulate foreign corporations without deterring investment, how to evaluate the actual cost of conditional aid, and how to build domestic industries capable of competing on a global stage. With debates over economic sovereignty growing across the Global South, this committee places delegates at the center of one of the defining arguments of our time.